STAT+: Congress has a chance to close the FDA’s Theranos loophole
WASHINGTON – Theranos, and the company’s notoriously inaccurate blood tests, could potentially have been stopped earlier if Congress had acted to fix a regulatory loophole.
Lawmakers are weighing now whether it’s better late than never.
Continue to STAT+ to read the full story…
Read Original Article: STAT+: Congress has a chance to close the FDA’s Theranos loophole »
